{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:39:31Z","timestamp":1759624771647,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["97-01-54-37196"],"award-info":[{"award-number":["97-01-54-37196"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.clineuro.2024.108171","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:18:06Z","timestamp":1707783486000},"page":"108171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The investigation of killer-cell immunoglobulin-like receptors (KIRs) and their HLA ligands in Iranian patients with myasthenia gravis."],"prefix":"10.1016","volume":"238","author":[{"given":"Mobina","family":"Jalalvand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fereshteh","family":"Beigmohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaneh","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soroush","family":"Ehsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahebeh","family":"Rajabkhah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Madreseh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Akhtari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmadreza","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8164-8831","authenticated-orcid":false,"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-4310","authenticated-orcid":false,"given":"Shahriar","family":"Nafissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2024.108171_bib1","unstructured":"Beloor Suresh A.A.R. Myasthenia Gravis: StatPearls; 2022 [Available from: \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559331\/\u3009."},{"issue":"11","key":"10.1016\/j.clineuro.2024.108171_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser","year":"2021","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108171_bib3","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1212\/WNL.29.5.734","article-title":"Cellular immune response to acetylcholine receptor in myasthenia gravis: II. Thymectomy and corticosteroids","volume":"29","author":"Morgutti","year":"1979","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108171_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1941875210382918","article-title":"Myasthenic crisis","volume":"1","author":"Wendell","year":"2011","journal-title":"Neurohospitalist"},{"issue":"3","key":"10.1016\/j.clineuro.2024.108171_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000279334","article-title":"The incidence of myasthenia gravis: a systematic literature review","volume":"34","author":"McGrogan","year":"2010","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.clineuro.2024.108171_bib6","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI21545","article-title":"Induction of myasthenia by immunization against muscle-specific kinase","volume":"116","author":"Shigemoto","year":"2006","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108171_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/eci.12.34","article-title":"Muscle autoantibodies in myasthenia gravis: beyond diagnosis?","volume":"8","author":"Meriggioli","year":"2012","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108171_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clineuro.2024.108171_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00809","article-title":"CD4+ T cells of myasthenia gravis patients are characterized by increased IL-21, IL-4, and IL-17A productions and higher presence of PD-1 and ICOS","volume":"11","author":"\u00c7ebi","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108171_bib10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1212\/WNL.28.3.266","article-title":"Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange","volume":"28","author":"Newsom-Davis","year":"1978","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108171_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/ar1034","article-title":"Natural killer cells and autoimmunity","volume":"6","author":"French","year":"2004","journal-title":"Arthritis Res. Ther."},{"issue":"3-4","key":"10.1016\/j.clineuro.2024.108171_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/08830180109054413","article-title":"Human natural killer cell receptors and signal transduction","volume":"20","author":"Campbell","year":"2001","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.clineuro.2024.108171_bib13","unstructured":"CarringtonM.N.P.. The KIR gene cluster: national center for biotechnology information (US); 2003 [Available from: \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK10135\/\u3009."},{"issue":"7","key":"10.1016\/j.clineuro.2024.108171_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071777","article-title":"KIR receptors as key regulators of NK cells activity in health and disease","volume":"10","author":"D\u0119bska-Zielkowska","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.clineuro.2024.108171_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.cll.2018.08.001","article-title":"Diversity of killer cell immunoglobulin-like receptors and disease","volume":"38","author":"Rajalingam","year":"2018","journal-title":"Clin. Lab. Med."},{"issue":"Suppl 2","key":"10.1016\/j.clineuro.2024.108171_bib16","first-page":"5","article-title":"Pathological aspects of malignant and benign thymic disorders","volume":"31","author":"M\u00fcller-Hermelink","year":"1999","journal-title":"Ann. Med."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108171_bib17","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/mus.20854","article-title":"Frequency of seronegativity in adult-acquired generalized myasthenia gravis","volume":"36","author":"Chan","year":"2007","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108171_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1148\/radiology.201.2.8888243","article-title":"Thymus in myasthenia gravis: comparison of CT and pathologic findings and clinical outcome after thymectomy","volume":"201","author":"Nicolaou","year":"1996","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108171_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/WNL.55.1.7","article-title":"Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the quality standards subcommittee of the American academy of neurology","volume":"55","author":"Gronseth","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108171_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108171_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108171_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1399-0039.2009.01263.x","article-title":"Distribution of KIR genes in the Iranian population","volume":"74","author":"Tajik","year":"2009","journal-title":"Tissue Antigens"},{"issue":"3","key":"10.1016\/j.clineuro.2024.108171_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1744-313X.2010.00906.x","article-title":"Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR\u2013SSP assay","volume":"37","author":"Tajik","year":"2010","journal-title":"Int. J. Immunogenet."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108171_bib24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1399-0039.2007.00923.x","article-title":"Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments","volume":"70","author":"Vilches","year":"2007","journal-title":"Tissue Antigens"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108171_bib25","first-page":"135","article-title":"Improved KIR gene and HLA-C KIR ligand sequence-specific primer polymerase chain reaction genotyping using whole genome amplification","volume":"76","author":"Chainonthee","year":"2010","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.clineuro.2024.108171_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0198-8859(02)00373-7","article-title":"Relevance of KIR gene polymorphisms in bone marrow transplantation outcome","volume":"63","author":"Gagne","year":"2002","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108171_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/03009742.2017.1340510","article-title":"Association of killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands with susceptibility to Beh\u00e7et\u2019s\u200e disease","volume":"47","author":"Mohammad-Ebrahim","year":"2018","journal-title":"Scand. J. Rheumatol."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108171_bib28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3348\/kjr.2015.16.2.286","article-title":"Propensity score matching: a conceptual review for radiology researchers","volume":"16","author":"Baek","year":"2015","journal-title":"Korean J. Radiol."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108171_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12881-019-0754-6","article-title":"Association study between KIR polymorphisms and rheumatoid arthritis disease: an updated meta-analysis","volume":"20","author":"Aghaei","year":"2019","journal-title":"BMC Med. Genet."},{"issue":"8","key":"10.1016\/j.clineuro.2024.108171_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.humimm.2015.06.017","article-title":"Association between KIR gene polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis","volume":"76","author":"Li","year":"2015","journal-title":"Hum. Immunol."},{"issue":"10","key":"10.1016\/j.clineuro.2024.108171_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006166","article-title":"Association between killer cell immunoglobulin-like receptor (KIR) polymorphisms and systemic lupus erythematosus (SLE) in populations: A PRISMA-compliant meta-analysis","volume":"96","author":"Liang","year":"2017","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.clineuro.2024.108171_bib32","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3109\/14397595.2014.894489","article-title":"Association between KIR polymorphisms and ankylosing spondylitis in populations: a meta-analysis","volume":"24","author":"Fan","year":"2014","journal-title":"Mod. Rheumatol."},{"issue":"52","key":"10.1016\/j.clineuro.2024.108171_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009439","article-title":"Association between KIR gene polymorphisms and type 1 diabetes mellitus (T1DM) susceptibility: a PRISMA-compliant meta-analysis","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108171_bib34","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s40200-020-00569-2","article-title":"Association of KIR gene polymorphisms with type 1 diabetes: a meta-analysis","volume":"19","author":"Soltani","year":"2020","journal-title":"J. Diabetes Metab. Disord."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108171_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1450","article-title":"Circulating CXCR5+ natural killer cells are expanded in patients with myasthenia gravis","volume":"12","author":"Ge","year":"2023","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.clineuro.2024.108171_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107880","article-title":"Natural killer cells promote the differentiation of follicular helper T cells instead of inducing apoptosis in myasthenia gravis","volume":"98","author":"Liu","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.clineuro.2024.108171_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1687-x","article-title":"CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells","volume":"16","author":"Yang","year":"2019","journal-title":"J. Neuroinflamm."},{"issue":"9","key":"10.1016\/j.clineuro.2024.108171_bib38","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.bbmt.2015.05.002","article-title":"Impact of KIR and HLA genotypes on outcomes after reduced-intensity conditioning hematopoietic cell transplantation","volume":"21","author":"Sobecks","year":"2015","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"2-3","key":"10.1016\/j.clineuro.2024.108171_bib39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/08820139.2020.1713145","article-title":"Association study between psoriatic arthritis and killer immunoglobulin-like receptor (KIR) genes: a meta-analysis","volume":"50","author":"Enciso-Vargas","year":"2021","journal-title":"Immunol. Investig."},{"issue":"10","key":"10.1016\/j.clineuro.2024.108171_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002270","article-title":"KIR2DL2 Enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection","volume":"7","author":"Seich al Basatena","year":"2011","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.clineuro.2024.108171_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2016.03.007","article-title":"KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients","volume":"294","author":"Rizzo","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.clineuro.2024.108171_bib42","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1177\/0961203316638931","article-title":"Analysis of killer cell immunoglobulin-like receptors and their human leukocyte antigen-ligands gene polymorphisms in Iranian patients with systemic lupus erythematosus","volume":"25","author":"Akhtari","year":"2016","journal-title":"Lupus"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724000581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724000581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:44:52Z","timestamp":1759589092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846724000581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":42,"alternative-id":["S0303846724000581"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108171","relation":{},"ISSN":["0303-8467"],"issn-type":[{"type":"print","value":"0303-8467"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The investigation of killer-cell immunoglobulin-like receptors (KIRs) and their HLA ligands in Iranian patients with myasthenia gravis.","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108171"}}